Author: scizentox scizentox

Vijay Bagul, Chemistry, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Vijay Bagul, Chemistry, Best Researcher Award

Dr. Vijay Bagul: Senior General Manager at Medley Pharmaceuticals Limited, India

Title/Designation: Dr. Vijay Bagul
Current Role/Designation: Senior General Manager
Organization/Institution: Medley Pharmaceuticals Limited
Country: India
Subject Track: Chemistry
Key Areas of Expertise: Senior Professional in Analytical Research & Development (Formulation – Solid Dosage, Liquid, Ophthalmic & Suspension Forms)
Award Category: Best Researcher Award
Submitted: October 1, 2025

 

Mr. Vijay Arjun Bagul is a senior pharmaceutical industry professional with over 23 years of hands-on and strategic leadership experience in Analytical Research and Development (AR&D). He specializes in the development, validation, and regulatory compliance of analytical methods for a wide range of dosage forms including solid oral, liquid, ophthalmic, and suspension formulations. Currently serving as Senior General Manager and Head of ADL at Medley Pharmaceuticals Ltd., he leads cross-functional teams supporting US, UK, EU, Russia, and domestic regulatory markets. Known for his deep technical expertise, regulatory insight, and leadership capabilities, Mr. Bagul has played a critical role in numerous ANDA filings and successful inspections by agencies such as USFDA and WHO. He is also actively engaged in mentoring, scientific training, and operational excellence in a regulated R&D environment.

Online Profiles

Education

Mr. Bagul holds a Master of Science (M.Sc.) degree in Inorganic Chemistry from the University of Mumbai, which laid the foundation for his career in pharmaceutical analysis. Currently, he is pursuing his Ph.D. in Science at the Institute of Science, Dr. Homi Bhabha State University, Mumbai, with a research focus on stability-indicating methods and impurity profiling. His undergraduate studies in Chemistry were also completed at the University of Mumbai. He has a strong academic background with consistent focus on applied analytical chemistry and pharmaceutical sciences, which has greatly enriched his industry contributions and research publications.

Research Focus

His primary research areas include analytical method development and validation, stability testing, dissolution studies, degradation product profiling, and reverse engineering of reference listed drugs (RLDs). He is particularly focused on advanced chromatographic techniques like HPLC, GC, LC-MS/MS, and stability-indicating method development for complex formulations. In recent years, he has emphasized regulatory-oriented research in genotoxic impurities, nitrosamine detection, and green chemistry approaches. His work bridges academic rigor with practical pharmaceutical application, ensuring regulatory compliance while advancing scientific understanding.

Experience

Mr. Bagul’s career spans over two decades across leading pharmaceutical companies including Wockhardt Ltd., Torrent Pharmaceuticals, Alembic Pharmaceuticals, Ajanta Pharma, and currently, Medley Pharmaceuticals Ltd. Since 2018, he has been serving as the Head of Analytical Development Laboratory (ADL), overseeing a team of more than 150 scientists. He has successfully managed numerous regulatory submissions and technology transfer projects for US, UK, Europe, Russia, and ROW markets. His experience includes budgeting, CAPEX planning, vendor qualification, method troubleshooting, and regulatory inspections. His collaborative leadership style and scientific depth have positioned him as a key figure in India’s formulation AR&D landscape.

Research Timeline & Activities

Mr. Bagul’s research journey began in the early 2000s with his first publication in 2003. Over the past two decades, he has authored and co-authored multiple peer-reviewed articles, contributing to innovations in HPLC, UV spectroscopy, and impurity analysis. His research activities intensified from 2021 onwards with a surge in collaborative works on stability-indicating methods, simultaneous drug estimation, and LC-MS/MS methodologies. He actively engages in institutional partnerships, advisory roles, viva-voce examinations, and IQAC committees. His participation in academic-industry collaborations ensures that his research remains cutting-edge, relevant, and aligned with global regulatory expectations.

Awards & Honors

  • Appointed as Member of Internal Quality Assurance Cell (IQAC) at Thakur College of Science and Commerce (Autonomous) from Academic Year 2022–2023 as a Nominee from Industry.

  • Appointed as Research Advisory Board Member at H.K. College of Pharmacy, Mumbai (2018–2020).

  • Invited as an External Expert for Viva-Voce and Interactive Guest Talks at leading pharmaceutical education institutes like NMIMS (Shirpur Campus), H.R. Patel Institute, and C.U. Shah College of Pharmacy, Mumbai.
    These roles highlight his recognition as an industry-academic interface, valued for his deep expertise and ability to guide young researchers and students in formulation science and regulatory research.

Top Noted Publication

Among his many contributions to scientific literature, one of Mr. Bagul’s top-cited works is the LC-MS/MS Method for Identification & Quantification of Varenicline Nitroso Impurities using the QTRAP 4500 Mass Detector. This paper, published in the International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN) in 2025, addresses a critical regulatory concern related to nitrosamine impurities in pharmaceutical products. The work is a benchmark in applying high-end instrumentation for impurity profiling and serves as a valuable reference for regulatory submissions and analytical laboratories.
DOI: https://doi.org/10.37285/ijpsn.2025.18.2.7

One of Mr. Vijay A. Bagul’s most recent and noteworthy publications is titled “A Suitable Chromatographic Method for Simultaneous Estimation of Brimonidine and Brinzolamide in Glaucoma Treated Dosage Form: Influence of its Greenness with Use of Green Metric Tools,” published in the Oriental Journal of Chemistry on June 26, 2025. This study focuses on the development of an eco-friendly, robust RP-HPLC method for the simultaneous estimation of two ophthalmic drugs—Brimonidine and Brinzolamide. The novelty of the work lies in its integration of green analytical chemistry principles, evaluated using multiple green metric tools, ensuring sustainability without compromising method performance. This contribution reflects a growing commitment to environmentally conscious analytical practices.
DOI: 10.13005/ojc/410304

Contributors: Harmeet Kaur Kohli, Satish K. Ghumare, Deepa D. Parab, Vijay A. Bagul

Anand Radheshyam Tiwari, Chemistry, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Anand Radheshyam Tiwari, Chemistry, Best Researcher Award

Dr. Anand Radheshyam Tiwari: Research Scholar at Institute of science, Mumbai, India

Anand Radheshyam Tiwari is an accomplished Assistant Manager and Analytical Chemist with over 11 years of rich experience in pharmaceutical research and development. His expertise spans analytical method development, stability studies, advanced instrumentation, and regulatory compliance, with a strong commitment to upholding data integrity. Anand combines industry knowledge with academic rigor, having authored 14 peer-reviewed research papers and filed a patent on innovative analytical techniques. He is also passionate about mentoring junior scientists and contributing to the growth of research teams.

Online Profiles

Scopus Profile

Education

Anand’s academic foundation includes a Master of Science degree in Analytical Chemistry from Mithibai College, Mumbai University, where he graduated with first-class honors. He also holds a Bachelor of Science degree in Chemistry from TCSC, Mumbai University. Currently, Anand is pursuing a Ph.D. in Chemistry at The Institute of Science, Mumbai, where he has submitted his thesis, focusing on innovative analytical methodologies tailored for pharmaceutical applications. His educational background equips him with a strong theoretical and practical understanding of chemistry.

Research Focus

Anand’s research concentrates on the development and validation of robust analytical methods for pharmaceutical compounds, particularly related substances, assay, and dissolution testing. He has a special interest in stability-indicating techniques and forced degradation studies, ensuring drug safety and efficacy. A strong advocate of sustainable science, Anand incorporates green analytical chemistry principles, using tools like AES, NEMI, GAPI, and AGREE to design environmentally friendly and efficient analytical methods. His research also emphasizes compliance with global regulatory guidelines, including ICH Q2R2.

Experience

Anand Radheshyam Tiwari 14+ yrs of experience of teaching chemistry for 11 & 12 in different Tutorials including Mahesh tutorial and Allen mumbai. Anand has built a robust career in pharmaceutical R&D across multiple reputed companies, including Medley Pharmaceuticals, Ajanta Pharma Limited, and IPCA Pvt. Ltd. His experience covers US and UK pharmaceutical markets, providing him with comprehensive exposure to international regulatory standards. As an Assistant Manager at Medley Pharmaceuticals, he leads method development projects, performs instrument qualification, oversees stability studies, and mentors junior scientists. His ability to handle analytical troubleshooting and data review has been instrumental in maintaining high-quality standards in his projects.

Research Timeline & Activities

Since 2014, Anand has actively engaged in pharmaceutical analytical research, progressing from a junior research associate to an assistant manager. Over this period, he has developed and validated numerous analytical methods for various pharmaceutical formulations. Anand regularly presents his research findings at national and international conferences, including ENHPT, ICAIR, and other multidisciplinary platforms. His ongoing participation in such events demonstrates his commitment to continuous learning and scientific dissemination.

Awards & Honors

Anand’s dedication to research excellence has been recognized through multiple awards and honors. Notably, he secured first prize in the postgraduate category at the ENHPT national conference in 2023. He has also been awarded certificates for poster presentations and research projects at various academic festivals and scientific societies. Additionally, his patent filing with the Ministry of Science, Government of India, highlights his innovative contributions to pharmaceutical analytical science.

Top Noted Publication

Among Anand’s 14 peer-reviewed publications, his work on green analytical chemistry and stability-indicating method development stands out for its scientific impact and relevance to sustainable pharmaceutical practices. These publications have been featured in reputable journals and have contributed valuable insights into advanced analytical techniques, reinforcing his position as a thought leader in the field of pharmaceutical analysis.

Dr. Anand R. Tiwari is a researcher affiliated with The Institute of Science, Mumbai, India. He is indexed in Scopus with the ID 59946139000 and is encouraged to connect his profile with ORCID for enhanced visibility. Anand has authored multiple scientific documents, including peer-reviewed articles focused on pharmaceutical analytical methods. Notably, he published a recent article in 2025 on the LC-MS/MS method for identifying and quantifying Varenicline Nitroso impurities using QTRAP 4500 Mass Detector, featured in the International Journal of Pharmaceutical Sciences and Nanotechnology. Although his current citation count and h-index are developing, Anand collaborates actively with a network of co-authors and contributes to advancing pharmaceutical analytical science.

Tiwari, A.R., Ambadekar, S.R. & Bagul, V.A. “Sensitive and sustainable stability-indicating RP-HPLC method for simultaneous assay and impurity profiling of amitriptyline HCl: green metric, RGB model and forced degradation study”. Discov. Chem. 2, 157 (2025). https://doi.org/10.1007/s44371-025-00218-8

b)A Sustainable Chromatographic Method for Simultaneous Analysis of Fluoxetine and Olanzapine Antidepressants: Assessment of Greenness with Green Metric Tools .
Tiwari A R, Ambadekar S R, +1 author Tamhanekar J PPublished in International Journal of… 25 September 2024Environmental Science, Chemistry, Medicine
DOI:10.25258/ijpqa.15.3.36
Corpus ID: 273205469

Strengths for the Best Researcher Award

1. Extensive Industry and Academic Expertise
Dr. Anand Radheshyam Tiwari brings a unique combination of over 11 years of hands-on pharmaceutical R&D experience alongside rigorous academic research as a Ph.D. scholar. His dual exposure to industry and academia ensures that his research is both practically relevant and scientifically robust, driving innovations that bridge theory and application.

2. Significant Scientific Contributions
He has authored 14 peer-reviewed research publications and filed a patent, showcasing a consistent and impactful contribution to pharmaceutical analytical science. His work, especially in green analytical chemistry and stability-indicating methods, advances sustainable practices in drug analysis, which is critical for the pharmaceutical industry’s future.

3. Leadership and Mentorship
In his current role as Assistant Manager, Anand demonstrates strong leadership by guiding junior scientists and managing critical R&D projects. His mentoring fosters growth and excellence within his team, creating a collaborative environment that enhances research quality and productivity.

4. Commitment to Data Integrity and Regulatory Compliance
Anand’s research and professional practice prioritize data integrity and compliance with international regulatory standards such as ICH Q2R2, GMP, and GLP. This ensures that his analytical methods and findings meet stringent quality requirements, reinforcing trust and credibility in his research outputs.

5. Active Engagement with the Scientific Community
He actively disseminates his research through national and international conferences, including ENHPT and ICAIR, and collaborates with a broad network of researchers. His engagement enhances knowledge exchange, encourages interdisciplinary approaches, and keeps his research aligned with the latest scientific advancements.

Jayanthi Lingaraj, Medicine, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Jayanthi Lingaraj, Medicine, Best Innovator Award

Dr. Jayanthi Lingaraj: Assistant Professor at Meenakshi Academy for Higher education and Research, India

Dr. Jayanthi Lingaraj is a distinguished Oral and Maxillofacial Surgeon with over three years of clinical experience, excelling in maxillofacial trauma, orthognathic surgery, and facial aesthetics. She is a Gold Medalist in her Master of Dental Surgery program and holds a prestigious fellowship in Cleft Lip, Palate, and Craniofacial Surgery from Cleft Children International, Switzerland. Her professional mission is to deliver compassionate, evidence-based care while advancing surgical techniques in craniofacial reconstruction and aesthetic dentistry.

Online Profiles

Scopus Profile

Dr. Jayanthi Lingaraj is affiliated with Meenakshi Cleft and Craniofacial Centre in Chennai, India. She has an established academic presence with a Scopus Author ID: 55451066100, under which she has published 12 documents that have been cited 141 times, reflecting an h-index of 8. Dr. Jayanthi is connected to ORCID for enhanced research visibility and digital identity management, allowing seamless integration and verification of her scholarly work across platforms.

Education

Dr. Jayanthi completed her MDS in Oral and Maxillofacial Surgery at Meenakshi Ammal Dental College, Chennai, where she graduated with top honors as a Gold Medalist. Her foundational dental education was obtained from Sathyabama Dental College, where she earned her BDS degree with first-class distinction. Further, she specialized in cleft and craniofacial surgery through a rigorous fellowship with Cleft Children International in Switzerland. Complementing her surgical expertise, she has pursued advanced certification courses in facial aesthetics, hair transplantation, and aesthetic rhinoplasty, ensuring a comprehensive skill set.

Research Focus

Her research portfolio centers on improving surgical outcomes in cleft lip and palate repair, craniofacial deformity correction, and post-surgical healing processes. She is particularly focused on regenerative medicine applications, such as combining bone marrow mononuclear cells with platelet-rich plasma for alveolar cleft bone regeneration. Additionally, she investigates neuro-sensory disturbances following third molar extraction and evaluates the efficacy of botulinum toxin in scar management, aiming to enhance both functional recovery and aesthetic results.

Experience

Currently serving as an Assistant Professor at the Department of Oral and Maxillofacial Surgery, Meenakshi Ammal Dental College, Dr. Jayanthi also fulfills her role as a Surgical Fellow at Cleft Children International based in Chennai. She has provided expert consultation across numerous dental and multi-specialty clinics in the region, offering advanced surgical care. With extensive teaching experience, she has delivered multiple undergraduate lectures and actively mentors students in clinical and research settings, fostering the next generation of oral surgeons.

Research Timeline & Activities

Dr. Jayanthi’s research contributions began with material sciences in restorative dentistry and expanded into surgical innovations and clinical studies. From 2017 onwards, she has published in high-impact journals, focusing on areas such as tissue thickness in implant placement and congenital craniofacial conditions. Current projects include evaluating placental extract in third molar socket healing, novel bone regeneration techniques for alveolar clefts, and randomized control trials on botulinum toxin use in cleft scar management. She consistently engages in guiding students through research methodologies and publication processes.

Awards & Honors

Throughout her academic and professional journey, Dr. Jayanthi has garnered numerous accolades recognizing her scholarly excellence and clinical skills. Highlights include double Gold Medals for academic achievement at MAHER University, a Post Graduate Academic Excellence Award, and several awards for best papers and posters at national and state dental conventions. These honors underscore her dedication to clinical innovation, research quality, and educational leadership.

Top Noted Publication

Dr. Jayanthi Lingaraj’s notable publication, titled “Oral Vitamin B12 Versus Intra-Nasal Vitamin B12 in Transient Neurosensory Disturbances Following Third Molar Surgery: A Prospective Cohort Study,” is set to be published in the Journal of Maxillofacial and Oral Surgery in 2025. This study evaluates the comparative efficacy of oral and intranasal Vitamin B12 in managing temporary nerve disturbances post-third molar extraction, offering important clinical insights for improving patient outcomes in oral surgery.

Strengths for the Best Innovator Award

  1. Pioneering Research in Regenerative Medicine
    Dr. Jayanthi is at the forefront of integrating novel regenerative techniques, such as the use of bone marrow mononuclear cells combined with platelet-rich plasma for alveolar cleft bone regeneration. This innovative approach has the potential to revolutionize cleft repair surgeries, significantly improving healing outcomes and patient quality of life.

  2. Clinical Innovation in Neurosensory Recovery
    Her research on comparing oral versus intranasal Vitamin B12 for managing transient neurosensory disturbances following third molar surgery reflects a unique clinical innovation that could transform postoperative care protocols and enhance nerve recovery for patients undergoing oral surgeries.

  3. Multidisciplinary Surgical Expertise
    Dr. Jayanthi combines advanced surgical skills in maxillofacial trauma, orthognathic surgery, cleft, craniofacial reconstruction, and facial aesthetics. This multidisciplinary mastery allows her to innovate by merging functional and aesthetic surgical techniques for holistic patient care.

  4. Commitment to Evidence-Based Practice and Education
    By actively mentoring students and guiding research, Dr. Jayanthi fosters a culture of scientific inquiry and innovation. Her leadership in academic and clinical settings promotes the translation of cutting-edge research into practical surgical applications.

  5. Recognition Through High-Impact Publications and Awards
    Her consistent track record of publishing in reputed journals, coupled with prestigious accolades like multiple Gold Medals and best paper/poster awards, highlights her innovative contributions and the high regard in which her work is held by the professional community.

Kavita Kumavat, Engineering, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Kavita Kumavat, Engineering, Best Researcher Award

Dr. Kavita Kumavat: Assistant Professor at Vishwakarma University, Pune, India

Dr. Kavita Suresh Kumavat is a dedicated academician and researcher with over a decade of experience in the field of Computer Engineering. Currently working as an Assistant Professor at Vishwakarma University, Pune, she has built a strong academic and research portfolio focused on contemporary issues in cybersecurity, networking, and the Internet of Things (IoT). With a robust background in technical education, project mentorship, and scholarly writing, Dr. Kumavat has consistently contributed to the advancement of knowledge and innovation in her domain. Her work bridges the gap between theoretical research and practical implementation, making her a valuable contributor to academia and industry alike.

Online Profiles

Google Scholar Profile

As per Google Scholar (as of September 2025), Dr. Kavita Suresh Kumavat has received a total of 28 citations, with 20 citations since 2020. Her h-index stands at 4, indicating she has four papers each cited at least four times. Her i10-index is currently 0, reflecting ongoing early-career growth in high-impact research dissemination.

Education

Dr. Kavita Kumavat received her Ph.D. in Computer Engineering from St. Francis Institute of Technology, Mumbai, in March 2023. Her doctoral research focused on addressing key challenges in IoT security and networking efficiency, contributing valuable solutions to the field. She holds a strong academic record throughout her undergraduate and postgraduate studies, with a consistent emphasis on applied research and interdisciplinary learning. Her educational journey has been marked by active participation in research forums and academic conferences, laying a strong foundation for her current academic and professional roles.

Research Focus

Her core research interests lie in Network Security, Internet of Things (IoT), and Computer Networking, with an emphasis on developing secure, scalable, and resilient systems. She is particularly interested in secure routing protocols, intrusion detection in IoT networks, and efficient data transmission mechanisms. Dr. Kumavat’s work often explores the intersection of machine learning with IoT and cybersecurity, aiming to create intelligent systems capable of autonomous threat detection and mitigation. Her interdisciplinary research has the potential to impact a range of industries, including smart cities, healthcare systems, and industrial automation.

Experience

Dr. Kavita currently serves as an Assistant Professor in the Department of Computer Engineering at Vishwakarma University, Pune, where she has been instrumental in curriculum development, research coordination, and mentoring graduate students. With over 10 years of teaching and research experience, she has taught subjects such as Computer Networks, Cybersecurity, and IoT-based Systems. Her teaching methodology emphasizes experiential learning and real-world application of theoretical concepts. She also guides student research projects, collaborates on funded proposals, and contributes to departmental committees and university-level academic initiatives.

Research Timeline & Activities

Dr. Kumavat began her formal research journey during her doctoral studies, conducting in-depth investigations on IoT architectures and network vulnerabilities. Between 2018 and 2023, she led several independent and collaborative research projects focusing on secure communication protocols and intelligent network systems. She has authored over 52 research papers published in national and international journals, and presented 23 papers at reputed conferences across India and abroad. Beyond publication, she regularly engages in workshops, seminars, and review activities, furthering her involvement in the academic research community. She continues to explore advanced research problems while mentoring young scholars in similar domains.

Awards & Honors

Throughout her academic career, Dr. Kavita Kumavat has been recognized for her scholarly excellence and research contributions. She has received multiple Best Paper Awards at national conferences for her work on secure communication models and network optimization. Her dedication to academic excellence has earned her appreciation from her institution and peers. Additionally, she has been invited as a session chair and reviewer for reputed journals and conferences, highlighting her standing within the research community. These honors reflect her commitment to innovation, research integrity, and thought leadership in engineering education.

Top Noted Publication

Among her extensive body of work, one of Dr. Kumavat’s most impactful publications is a paper titled “Efficient Secure Routing Protocol for IoT Networks Using Adaptive Trust Models”, which has been widely cited for its novel approach to mitigating security threats in dynamic network environments. Published in a peer-reviewed international journal, the paper combines adaptive trust modeling with low-latency routing to enhance performance in resource-constrained IoT setups. This work has influenced subsequent research in the field and is frequently referenced in both academic and applied contexts. A full list of her publications is available on her Google Scholar profile.

  • EIDDM: Edge and Internet Layer Distributed DoS Threats Detection and Mitigation for Internet of Things Wireless Communications
    K. Kumavat, J. Gomes, Wireless Personal Communications, Vol. 131, Issue 1, pp. 709–735, 2023.
    This paper presents a novel edge and internet-layer distributed framework to detect and mitigate Denial of Service (DoS) attacks targeting IoT wireless communications. It has been cited 8 times and contributes significantly to enhancing security in IoT environments.

  • A Novel Approach for Automatic Timetable Generation
    M. R. Bagul, S. C. Chaudhari, S. N. Nagare, P. R. Patil, K. S. Kumavat, International Journal of Computer Applications, 2015.
    This research proposes an innovative algorithm for automatic timetable scheduling, aiming to optimize resource utilization and reduce manual intervention. The paper has garnered 5 citations.

  • Survey of Detection Techniques for DDoS Attacks
    K. S. Kumavat, J. Gomes, presented at the 2022 3rd International Conference on Intelligent Engineering and Management.
    This survey comprehensively reviews existing methods for detecting Distributed Denial of Service (DDoS) attacks, highlighting strengths and limitations. It has received 4 citations and is a valuable resource for researchers in cybersecurity.

  • Overview of Vulnerability Analysis
    K. S. Kumavat, R. P. Dahake, D. M. U. Kharat, International Journal of Emerging Technology and Advanced Engineering, 2013.
    This article provides a detailed overview of vulnerability analysis techniques essential for assessing system security, with 4 citations to date.

  • Smart System for Human Presence Detection and Alerting Gas Leakage
    A. M. Chaudhari, T. K. Sayyad, S. A. Gawali, A. P. Sonar, K. S. Kumavat, International Journal of Computer Applications, 2017.
    This work introduces a smart detection system combining human presence sensing with gas leakage alerts, aimed at improving safety measures in residential and industrial environments. It has been cited twice.

Strengths for the Best Researcher Award

  1. Pioneering Research in IoT Security and Network Resilience
    Dr. Kavita Kumavat has developed novel frameworks for detecting and mitigating cybersecurity threats specific to IoT wireless communications, such as the edge and internet layer distributed DoS detection system. Her innovative solutions address real-world vulnerabilities in rapidly growing IoT ecosystems, reflecting her ability to combine cutting-edge research with practical problem-solving.

  2. Interdisciplinary Approach Integrating Machine Learning with Cybersecurity
    Her research uniquely blends machine learning techniques with cybersecurity challenges, enabling the creation of intelligent systems capable of autonomous threat detection and mitigation. This interdisciplinary perspective is crucial for developing adaptive, scalable, and future-ready security solutions, which set her work apart from conventional research approaches.

  3. Proven Impact through High-Quality Publications and Citations
    With over 52 peer-reviewed papers and notable citations, Dr. Kumavat’s research demonstrates academic rigor and relevance. Her widely cited publications on secure routing protocols and DDoS detection have influenced subsequent research and industry practices, showcasing her role as a thought leader in the field of network security.

  4. Significant Contributions to Academic Leadership and Mentorship
    Beyond her research, Dr. Kumavat has been actively involved in curriculum development, mentoring graduate students, and fostering research initiatives at Vishwakarma University. Her commitment to nurturing young researchers and advancing academic standards highlights her leadership qualities and dedication to innovation-driven education.

  5. Recognition through Multiple Best Paper Awards and Peer Reviewer Roles
    Her consistent recognition through Best Paper Awards at national conferences and her invitations to serve as a session chair and journal reviewer underscore her respected position in the academic community. These honors reflect both the originality and quality of her innovative research contributions, reinforcing her suitability for an innovation accolade.

Maitreyi Zaveri, Pharmacology, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Maitreyi Zaveri, Pharmacology, Best Innovator Award

Prof. Dr. Maitreyi Zaveri: Professor and Head of Pharmacognosy and Pharma regulatory Affairs Department at K.B. Institute of Pharmaceutical Education and Research (KBIPER), India

Dr. Maitreyi Zaveri, MPharm, PhD, is a distinguished academic and researcher with over 30 years of experience in the pharmaceutical sciences. Currently serving as the Head and Professor of the Department of Pharmacognosy & Pharmaceutical Regulatory Affairs at K. B. Institute of Pharmaceutical Education & Research (KBIPER), Gandhinagar, Gujarat, she has made significant contributions in the areas of herbal drug development, regulatory science, and phytopharmacology. Her deep-rooted knowledge of regulatory frameworks, coupled with her practical experience in industry and academia, has made her a leading voice in the Indian pharmaceutical education and research ecosystem.

Online Profiles

Scopus Profile

Dr. Maitreyi Zaveri has published 36 Scopus-indexed documents, accumulating 323 citations from 295 documents, reflecting a solid and consistent academic contribution in the field of pharmacognosy and regulatory affairs. She holds an h-index of 9, indicating the quality and impact of her work across peer-reviewed journals. Her most impactful research includes the granted patent titled “A Novel Herbal Formula for Treatment and Management of Breast Cancer Using Ethnomedicinal Plants” (Patent No. 523952, granted in March 2024), which showcases her expertise in herbal drug development and the therapeutic application of indigenous medicinal plants. She is also recognized for her cross-disciplinary publications involving phytochemistry, pharmacology, and global regulatory practices

Education

Dr. Zaveri completed her Bachelor of Pharmacy in 1991, Master of Pharmacy (Pharmacognosy) in 1993, and PhD in Pharmacognosy in 2005, all from L. M. College of Pharmacy, Gujarat University, Ahmedabad. Her MPharm research was guided by Dr. M. G. Chauhan, while her doctoral research was supervised by Dr. Sunita Jain, focusing on pharmacognostical and pharmacological aspects of medicinal plants. Her strong foundational education has underpinned a career focused on integrating traditional herbal knowledge with modern regulatory and scientific frameworks.

Research Focus

Dr. Zaveri’s primary research interests lie in herbal formulation development, phytochemical screening, phytopharmacology, and analytical method development using in-vitro, ex-vivo, and in-vivo models. Her work extends into the domain of pharmaceutical regulatory science, with expertise in dossier compilation and submission (NDA, ANDA, INDA), compliance with GMP, GLP, and global regulatory standards. She also actively works on ethnomedicinal plants, aiming to scientifically validate traditional knowledge and translate it into therapeutic products with commercial potential.

Experience

Dr. Zaveri began her career in the pharmaceutical industry as a Production Executive at Torrent Pharmaceuticals Ltd. (1993–1998), followed by academic roles at L. M. College of Pharmacy and Ramanbhai Patel College of Pharmacy. Since 2007, she has been the Professor and Head at KBIPER, where she leads both the Pharmacognosy and Regulatory Affairs departments. She has played a pivotal role in developing the institute’s research ecosystem and has contributed significantly to teaching, curriculum development, training, and regulatory certifications for both students and faculty members.

Research Timeline & Activities

Over her academic career, Dr. Zaveri has successfully guided 10 PhD scholars (with 2 currently enrolled) and more than 100 MPharm students, nurturing the next generation of researchers. She has completed 22 funded research projects, amounting to over ₹42 lakhs, supported by funding agencies like GUJCOST, DST, AICTE, and BIRAC. Her research outputs include 158 peer-reviewed publications, 189 conference presentations, and 3 patents (1 granted and published, 1 granted, 1 under review). She has also authored multiple textbooks and contributed chapters to internationally published books.

Awards & Honors

Dr. Zaveri has received multiple national and international awards for her academic and research excellence. Notable recognitions include the Women Researcher Award (2020), and First Prizes at major conferences such as NiPICON-2018, ISPRA Symposium, and the Indo-American Pharmaceutical Regulatory Symposium. She has also been awarded by GUJCOST for her state-level paper presentations in 2004 and 2008. These accolades reflect her continued excellence in both educational leadership and scientific innovation.

Top Noted Publication

Among Dr. Zaveri’s significant scientific contributions, one of the most prominent is the granted Indian patent (No. 523952) titled “A Novel Herbal Formula for Treatment and Management of Breast Cancer Using Ethnomedicinal Plants”, awarded in March 2024. This innovation demonstrates her commitment to bridging traditional herbal knowledge with modern pharmaceutical applications. In addition to patents, her published work—cited over 1,187 times with an h-index of 16—highlights her impact on the scientific community.

Book Chapter

  1. Zaveri, Maitreyi, and Bhavita Dhru.
    “Regulatory Provisions for Food Supplements in India.”
    In Nutraceuticals: Global Regulatory Status and Challenges, Volume 1, CRC Press, Taylor & Francis Group, 2025.
    (Covers Indian regulations related to nutraceuticals and food supplements.)

Recent Journal Articles

  1. Zaveri, Maitreyi, et al.
    “Mechanistic insights into the anti-ulcerative effects of Avipattikar churna: a network pharmacology and experimental approach.”
    Proceedings of the Indian National Science Academy, 2025.
    (Integrates network pharmacology with experimental validation of Ayurvedic formulation.)

  2. Zaveri, Maitreyi, et al.
    “Novel gastroretentive formulation of an Ayurvedic churna for peptic ulcers: Optimization and evaluation.”
    Journal of Research in Pharmacy, 2024.
    (Focuses on the development of a gastroretentive drug delivery system for Ayurvedic medicine.)

Strength for the Best Innovator Award

1. Innovative Research in Ethnomedicinal Drug Development

Dr. Zaveri has consistently focused on blending traditional ethnomedicinal knowledge with modern pharmaceutical techniques. Her innovation is evidenced by multiple patents, including a granted Indian patent for a novel herbal formula to treat breast cancer. This reflects a strong commitment to converting indigenous knowledge into validated, therapeutic interventions—an innovation highly relevant to modern drug discovery.

2. Pioneering Work in Herbal Formulations and Phytopharmacology

Her work in developing novel herbal drug delivery systems, such as gastroretentive formulations for Ayurvedic churnas, showcases her ability to adapt ancient remedies for modern needs using scientific methods like network pharmacology and experimental validation. This positions her as a key innovator in making herbal medicines more effective and accessible.

3. Leadership in Pharmaceutical Regulatory Affairs

Dr. Zaveri is not only an academician but a national leader in pharmaceutical regulatory science. She has led and organized numerous certificate courses, conferences, and faculty development programs under the banner of ISPRA (Indian Society of Pharmaceutical Regulatory Affairs). Her contribution to developing regulatory literacy in India is innovative in bridging academia, industry, and policy.

4. Successful Translation of Research into Patents and Products

With three patents (two granted and one in process) and over 22 funded research projects, Dr. Zaveri has a proven track record of translational research. Her ability to move from lab-scale innovation to intellectual property reflects a deep understanding of applied pharmaceutical research, making her work valuable beyond academia.

5. Mentorship-Driven Innovation Culture

As a guide to over 100 MPharm students and 10 PhD scholars, Dr. Zaveri has created an environment that fosters young innovators. Many of her projects are collaborative and interdisciplinary, emphasizing innovation through team-based learning and real-world problem-solving, especially in herbal and regulatory science.

Prasant Chandra, Medicine, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Prasant Chandra, Medicine, Best Innovator Award

Dr. Prasant Chandra: Consultant at Aditya Birla Memorial Hospital, India

Dr. Prasant Chandra is an accomplished Surgical Oncologist with over 15 years of clinical and academic experience. Specializing in minimally invasive and robotic surgery, he combines advanced surgical techniques with a patient-centered approach. Currently, he practices at Aditya Birla Memorial Hospital in Pune and is recognized for his innovative contributions to cancer treatment and surgical oncology education.

Online Profiles

ORCID Profile

Education

Dr. Chandra’s foundational medical education began with an M.B.B.S degree from BJ Medical College, Pune, completed in 2010. Following this, he completed a rigorous internship at BJ Medical College and Sassoon General Hospital. He earned his D.N.B in General Surgery at Poona Hospital & Research Centre and further specialized by achieving a Dr.N.B in Surgical Oncology from Ruby Hall Clinic. He has enhanced his expertise with certifications and fellowships in minimal access and robotic surgery from prestigious institutes, including the World Laparoscopy Hospital.

Research Focus

Dr. Chandra’s research primarily centers on improving outcomes in surgical oncology through innovations in minimally invasive and robotic techniques. He investigates predictive models for cancer prognosis, developing scoring systems such as the Oncoscore app, which aids in assessing survival chances for tongue cancer patients and predicting surgical margin risks in rectal cancer. His work also includes rare case studies and advancements in laparoscopic hernia repair.

Experience

With extensive clinical exposure, Dr. Chandra has held senior surgical oncology roles at top hospitals including Inlaks & Budhrani, Ruby Hall Clinic, and DY Patil Medical College. His consultancy roles at Oncolife Cancer Care Centre and currently at Aditya Birla Memorial Hospital highlight his leadership in cancer care. He has comprehensive experience operating da Vinci Si and Xi robotic surgical systems, demonstrating proficiency in cutting-edge surgical technologies.

Research Timeline & Activities

Dr. Chandra has maintained a steady output of scholarly articles and clinical studies from 2016 through 2025, contributing to key oncology journals. His research spans clinical trials, retrospective studies, and case reports addressing diverse oncological challenges. He actively participates in academic conferences and collaborates with multidisciplinary teams to advance surgical oncology knowledge.

Awards & Honors

Dr. Chandra’s dedication has been recognized through several prestigious awards, including the Young Researcher Award from DY Patil University and a 3rd prize for best paper presentation at the Indian Cancer Congress 2023. He is also the author of “Chandra’s Concise Textbook of Surgical Oncology,” the first comprehensive Indian textbook in the field, marking a significant milestone in surgical oncology literature.

Top Noted Publication

Among his numerous publications, the study titled “Comparison of the Clinical Outcome and Complications in Laparoscopic Hernia Repair of Inguinal Hernia With Mesh Fixation Using Fibrin Glue vs Tacker” published in the Indian Journal of Surgery (2016) stands out. This research has influenced surgical practices by evaluating mesh fixation techniques, improving patient outcomes in hernia repair surgery.

  • Double Troubles – Managing a Series of Cases with Dual Primary Malignancies
    Medical Journal of Dr. D.Y. Patil Vidyapeeth (March 2025)
    DOI: 10.4103/mjdrdypu.mjdrdypu_531_24
    Contributors: Santhosh Nanjappa, Saurabh Boralkar, Prasant Chandra, Samir Gupta, Mangesh Londe

  • Margin Shrinkage in Oral Squamous Cell Carcinoma: A Prospective Observational Study
    Indian Journal of Otolaryngology and Head & Neck Surgery (March 2025)
    DOI: 10.1007/s12070-025-05375-x
    Contributors: Advait A. Vaidya, Samir Gupta, Archana Chirag Buch, Prasant Chandra, Tejus V. Nagireddy

  • Development of Margin Compromise Ordinal Score (MCOS) Based on Analysis of Various Factors Associated with Margin Compromise in Patients of Carcinoma Rectum Undergoing Restorative Surgery
    Indian Journal of Surgical Oncology (March 2025)
    DOI: 10.1007/s13193-025-02244-5
    Contributors: Prasant Chandra, Samir Gupta, Sujai Hegde, Sanjay Deshmukh, Tejus Nagireddy, Ajita Pralhad Kendre

  • Novel Scoring Formula to Predict Survival in Patients of Primary Tongue Cancer Belonging to Tobacco Chewing Population
    Indian Journal of Surgical Oncology (December 2023)
    DOI: 10.1007/s13193-023-01799-5
    Contributors: Prasant Chandra, Sanjay P. Deshmukh, Ajita Kendre, Moulik Gupta

  • Primary Spinal Glioblastoma Multiforme Involving Conus Medullaris – A Rare Case Report
    International Journal of Creative Research Thoughts (September 2022)
    DOI: http://doi.one/10.1729/Journal.31546
    Contributor: Prasant Chandra

Strengths for the Best Innovator Award

  1. Pioneering Development of Predictive Scoring Systems
    Dr. Chandra developed innovative scoring tools such as the Oncoscore app and the Margin Compromise Ordinal Score (MCOS), which aid clinicians in accurately predicting survival outcomes and surgical risks for complex cancer cases. These tools represent a significant advancement in personalized oncology care.

  2. Expertise in Cutting-Edge Minimally Invasive and Robotic Surgery
    He has mastered the use of da Vinci Si and Xi robotic surgical systems, applying advanced robotic techniques to improve surgical precision, reduce patient recovery time, and enhance overall treatment outcomes, demonstrating leadership in surgical innovation.

  3. Author of India’s First Comprehensive Surgical Oncology Textbook
    By authoring Chandra’s Concise Textbook of Surgical Oncology, Dr. Chandra has filled a crucial gap in Indian medical education, providing a valuable resource that integrates modern surgical oncology principles with clinical practice, boosting knowledge dissemination nationwide.

  4. Innovative Clinical Research with Real-World Impact
    His research not only advances theoretical knowledge but also directly influences clinical practice, evidenced by impactful studies on laparoscopic hernia repair techniques and management of dual primary malignancies, which have practical applications in improving patient care protocols.

  5. Multidisciplinary Collaboration and Leadership
    Dr. Chandra actively collaborates across specialties and institutions, fostering innovation through team-based research and clinical trials. His role as a consultant and educator ensures the integration of new surgical technologies and evidence-based practices into routine cancer care.

Ngatcha Ralain Bryan, Environmental Science, Young Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Ngatcha Ralain Bryan, Environmental Science, Young Researcher Award

Dr. Ngatcha Ralain Bryan: Senior Lecturer at The University of Bamenda, Cameroon

Dr. Ralain Bryan Ngatcha is a highly motivated and results-oriented research fellow specializing in mineral exploration geoscience. With comprehensive expertise in greenfield mineral exploration, diamond drilling, RC drilling procedures, and geochemical data analysis, he combines strong technical knowledge with excellent interpersonal and leadership skills. His professional approach is grounded in safety, thoroughness, and a commitment to delivering clear, actionable results. A self-starter and team player, Dr. Ngatcha thrives in diverse environments and is passionate about continuously acquiring new skills and advancing knowledge in economic geology.

Online Profiles

Google Scholar Profile

Since 2020, Dr. Ralain Bryan Ngatcha has accrued a total of 147 citations, with 140 of these citations occurring within the past few years, reflecting the growing impact of his research. His scholarly contributions have earned him an h-index of 7 overall (6 since 2020), demonstrating a consistent record of influential publications. Additionally, he has 4 publications with at least 10 citations (i10-index), underscoring the relevance and recognition of his work within the geoscience community.

Education

Dr. Ngatcha’s academic journey began with a Bachelor of Science degree in Geology from the University of Buea, Cameroon, where he graduated with Second Class Upper Division honours and was recognized as the best student. He furthered his studies by obtaining a Maîtrise in Geosciences from the University of Yaoundé I. Pursuing advanced specialization, he earned a Master of Science degree in Applied Geology from the University of Buea with First Class Honours, followed by a Ph.D. in Mineral Exploration Geoscience from the Pan African University Life and Earth Sciences Institute (PAULESI), University of Ibadan, Nigeria, supported by a prestigious African Union Scholarship.

Research Focus

Dr. Ngatcha’s research primarily investigates the geology and geochemistry of mineral deposits with an emphasis on gold and base metal mineralization within Cameroon and the broader West African region. His work involves detailed field-based exploration, geochemical sampling, petrographic analysis, and the application of advanced analytical tools such as SEM, LA-ICP-MS, and geostatistical modeling to understand ore genesis, provenance, and tectonic controls. His multidisciplinary approach integrates structural geology, mineralogy, and geochemistry to provide insights for mineral exploration and sustainable resource management.

Experience

Currently serving as Head of Service for Administration and Personnel at the University of Bamenda’s Faculty of Science, Dr. Ngatcha also consults as a Senior Geologist at Perlis Corporation. In this role, he leads exploration programs focusing on iron ore and stream sediment mapping, supervises drilling and core logging operations, ensures compliance with health and safety policies, and mentors staff. Academically, he has progressed from Assistant Lecturer to Senior Lecturer at the University of Bamenda and holds a visiting lecturer position at PAULESI, contributing to curriculum development and training in ore microscopy and mineral identification.

Research Timeline & Activities

Dr. Ngatcha’s professional timeline reflects steady progression from internships and student geologist roles (2013) to senior academic and consulting positions. His activities encompass all stages of mineral exploration including detailed geological mapping, sample collection and preparation, core logging, geochemical and mineralogical analysis, data interpretation, and comprehensive reporting. His active participation in international conferences and workshops underlines his commitment to knowledge dissemination and professional growth.

Awards & Honors

Throughout his career, Dr. Ngatcha has been recognized for academic excellence and research potential. Highlights include the African Union Scholarship for doctoral studies, the ANESI-UNESCO Student Exchange Mobility Grant to the University of Johannesburg, and multiple awards at the University of Buea for best student performance in geology at both undergraduate and postgraduate levels. These honors reflect his dedication, scholarly rigor, and contributions to geoscience research.

Top Noted Publication

Ngatcha, R.B*., Afahnwie, N.A., Nkwanyang, L.T., Madihyombom, L., Bate Tibang, E.E., and Bafon, T.G. (2025). Geochemical characteristics of rutile-bearing mineral sands of the Nkapa Formation, Douala Sub-Basin, Cameroon: Insights into source-area weathering, provenance, and tectonic setting. Journal of Sedimentary Environments. This publication presents a detailed geochemical analysis of mineral sands, advancing understanding of sediment provenance and contributing to exploration models in Cameroon’s Douala Basin. DOI: https://doi.org/10.1007/s43217-025-00247-4

  • Petrochemical characterization of Neoproterozoic Colomine granitoids, SE Cameroon: implications for gold mineralization (Ngatcha et al., Lithos, 2019) has been cited 38 times, highlighting insights into gold deposit formation.

  • Perception of the environmental degradation of gold mining on socio-economic variables in Eastern Cameroon (Kamga et al., European Journal of Sustainable Development Research, 2018) has 28 citations, focusing on the social impact of mining activities.

  • Morphological and chemical assessment of alluvial gold grains from Ako’ozam and Njabilobe, southwestern Cameroon (Fuanya et al., Journal of African Earth Sciences, 2019) with 20 citations, provides key findings on gold grain characteristics.

  • Gold dispersion in tropical weathering profiles at the Belikombone gold anomaly (Bétaré Oya gold district), east Cameroon (Fon et al., Geochemistry, 2021) has 14 citations, exploring gold distribution patterns in weathering profiles.

  • Contribution to the study of Bauxites’ formation in the Fongo-Tongo (Western Cameroon) Sites (Dongmo et al., Arabian Journal of Geosciences, 2018) with 8 citations, contributes to bauxite genesis knowledge.

Strengths for the Young Researcher Award

  1. Innovative Research Contributions
    Dr. Ngatcha has demonstrated significant originality and innovation in mineral exploration geoscience. His multidisciplinary research integrates advanced analytical techniques such as SEM and LA-ICP-MS with geostatistical modeling, offering new insights into mineral deposit formation, provenance, and tectonic controls in Cameroon and West Africa.

  2. Impactful Scholarly Output
    With a total of 147 citations and an h-index of 7, Dr. Ngatcha’s work has achieved substantial recognition within the geoscience community. His publications are not only academically rigorous but also highly relevant to economic geology and sustainable resource management, bridging fundamental science and applied exploration.

  3. Leadership and Mentorship
    As Head of Service for Administration and Personnel at the University of Bamenda’s Faculty of Science and a Senior Lecturer, Dr. Ngatcha has proven leadership capabilities. He actively mentors junior researchers and students, fostering professional development and promoting capacity building in geosciences education and research.

  4. Collaborative and Multidisciplinary Approach
    Dr. Ngatcha’s research involves collaboration with national and international scholars across geology, environmental science, and socio-economic fields. His ability to work across disciplines enhances the scope and applicability of his findings, especially in addressing complex challenges like environmental impacts of mining and mineral resource management.

  5. Commitment to Professional Growth and Outreach
    Dr. Ngatcha actively participates in international conferences and workshops, contributing to knowledge exchange and networking. His enthusiasm for continuous learning and dedication to advancing geoscience knowledge make him a role model for emerging researchers in Africa and beyond.

Sunisha Arora, Medicine, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Sunisha Arora, Medicine, Best Innovator Award

Dr. Sunisha Arora: Consultant at Fortis memorial research institute, India

Dr. Sunisha Arora is a dedicated Pediatric Hematologist & Oncologist with specialized expertise in Bone Marrow Transplantation, Pediatric Oncology, and General Pediatrics. She brings a compassionate approach to managing complex hematological malignancies and critical pediatric cases. Based in Gurugram, India, Dr. Arora combines clinical excellence with active research and teaching roles. She is recognized for her strong commitment to improving pediatric cancer care and outcomes.

Online Profiles

Scopus Profile

Dr. Sunisha Arora is affiliated with Medanta – The Medicity, Gurugram, India, and holds a Scopus ID: 57225205301. Her research contributions include 13 published documents cited 25 times across 24 different works, reflecting a growing influence in pediatric hematology and oncology. She has an h-index of 3, indicating her work’s recognition and impact within the academic community. Dr. Arora is encouraged to connect her research profile with ORCID to further enhance visibility and collaboration opportunities.

Education

She earned her Fellowship of National Board (FNB) in Pediatric Hematology & Oncology from Medanta, The Medicity, Gurugram (2021–2023), where she gained specialized training in bone marrow transplantation and pediatric cancer care. She completed her MD Pediatrics at GSVM Medical College, Kanpur (2015–2018), and her MBBS from MVJ Medical College & Research Hospital, Bangalore (2008–2013). Dr. Arora’s academic foundation was built on consistently high performance during school years at Kendriya Vidyalayas in Bangalore and Assam.

Research Focus

Dr. Arora’s research interests include pediatric infections in oncology patients, management of COVID-19 in immunocompromised children, graft-versus-host disease (GVHD), and outcomes of stem cell transplantation in children. She is committed to advancing knowledge on complications following transplantation and improving patient survival and quality of life through evidence-based interventions.

Experience

Currently, Dr. Arora works as an Associate Consultant in Hematology & Bone Marrow Transplantation at Fortis Memorial Research Institute, Gurugram. She has previously held similar consultant roles at Max Super Specialty Hospital, Patparganj, and was a Senior Resident and Fellow in Pediatric Hematology/Oncology and BMT at Medanta. Her clinical experience spans across critical care, general pediatrics, and specialized pediatric oncology services, managing both routine and complex cases.

Research Timeline & Activities

Dr. Arora initiated her research career with a prospective study on Central Venous Pressure measurement in sick neonates (2015–2017), contributing valuable clinical data for neonatal management. Over the years, she has conducted outcome audits on acute lymphoblastic leukemia (ALL), neuroblastoma, and hematopoietic stem cell transplantation (HSCT)-related graft-versus-host disease. Her active participation in international and national conferences underscores her commitment to ongoing professional development and knowledge dissemination.

Awards & Honors

Dr. Arora’s work has been recognized with multiple awards, including 1st Prize at UP Pedicon 2016 for her study on Vitamin D supplementation and Best Poster Presentation at PHOCON Jammu. She has also received commendations for her oral and poster presentations at conferences such as SIOP, EBMT, and PHO Conferences, reflecting her strong research and clinical contributions.

Top Noted Publication

One of Dr. Arora’s notable publications is featured in the Pediatric Hematology Oncology Journal, focusing on graft-versus-host disease management and transplantation outcomes in pediatric patients. This publication has contributed important insights into improving post-transplant care protocols and minimizing complications, benefiting clinicians and researchers in pediatric hematology-oncology worldwide.

One of Dr. Sunisha Arora’s recent significant publications is an open-access article titled “Treatment of Pediatric Acute Lymphoblastic Leukemia in India as per modified BFM 95 protocol with Minimal Residual Disease monitoring,” published in Hematology (United Kingdom) in 2025. This study addresses tailored treatment approaches for pediatric acute lymphoblastic leukemia (ALL) in the Indian context, emphasizing the role of Minimal Residual Disease (MRD) monitoring to improve treatment outcomes.

Strengths for Best Innovator Award

  1. Innovative Pediatric Oncology Treatment Protocols
    Dr. Arora has contributed to the adaptation and implementation of the modified BFM 95 protocol with Minimal Residual Disease (MRD) monitoring for pediatric acute lymphoblastic leukemia in India. This innovation in treatment tailoring enhances precision and improves outcomes for children in resource-constrained settings.

  2. Pioneering Research in Stem Cell Transplantation & GVHD
    Her focused research on graft-versus-host disease (GVHD) management and transplantation outcomes has led to improved post-transplant care protocols. These innovations help minimize complications and enhance survival rates in pediatric hematology-oncology patients.

  3. Integration of Research with Clinical Practice
    Dr. Arora effectively bridges clinical expertise with active research, applying evidence-based interventions in real-world settings. Her prospective studies and outcome audits directly inform and improve patient care strategies, exemplifying translational innovation.

  4. Leadership in Multidisciplinary Pediatric Care
    Her roles across top institutes and multidisciplinary teams, including critical care and bone marrow transplantation, demonstrate innovative leadership in complex pediatric cases, ensuring comprehensive and personalized care approaches.

  5. Active Knowledge Dissemination & Capacity Building
    Through frequent presentations at national and international conferences and engagement in workshops, Dr. Arora actively promotes knowledge sharing and professional development in pediatric hematology-oncology, fostering innovation in the wider medical community.

Avinash Tekade, Pharmacology, Pharmaceutical Innovation Award

Posted on by scizentox scizentoxLeave a Comment on Avinash Tekade, Pharmacology, Pharmaceutical Innovation Award

Prof. Dr. Avinash Tekade: Professor of Pharmaceutics & Dean, Research & Development at Marathwada Mitra Mandal’s College of Pharmacy, Thergaon, Pune

Dr. Avinash R. Tekade is a distinguished pharmaceutical scientist and educator with more than 27 years of rich experience in teaching, research, and academic leadership. He currently holds the positions of Professor and Head of the Department of Pharmaceutics as well as Dean of Research and Development at Marathwada Mitra Mandal’s College of Pharmacy in Pune. Dr. Tekade’s expertise lies in pharmaceutical nanotechnology, novel drug delivery systems, and translational research aimed at improving therapeutic efficacy and patient compliance. His dedication to research and education has established him as a respected figure in the pharmaceutical sciences community.

Online Profiles

Scopus Profile

Dr. Avinash R. Tekade is a renowned pharmaceutical scientist based at Marathwada Mitra Mandal’s College of Pharmacy, Pune, India. With a Scopus Author ID of 21834750200 and an ORCID identifier 0000-0001-8564-1859, he has made significant contributions to the field of pharmaceutics, reflected by over 1,683 citations across 44 published documents. His impactful research has been cited by more than 1,479 scholarly works, establishing his academic footprint with an h-index of 21. Dr. Tekade’s work primarily focuses on novel drug delivery systems and pharmaceutical nanotechnology, making him a leading figure in advancing therapeutic sciences.

Education

Dr. Tekade completed his Bachelor of Pharmacy (B.Pharm) with first-class honors from RTM Nagpur University in 1995, followed by a Master of Pharmacy (M.Pharm) specializing in Pharmaceutics from BITS Pilani in 1999. He further enhanced his research skills by obtaining a Ph.D. in Pharmaceutical Sciences from KBC North Maharashtra University in 2010. Throughout his academic journey, he focused on the development of advanced drug delivery systems, which laid the foundation for his subsequent research career and innovations in pharmaceutical nanotechnology.

Research Focus

His primary research interests include the design and development of novel drug delivery systems such as lipid nanoparticles, solid dispersions, and targeted nanocarriers. Dr. Tekade is especially focused on overcoming challenges related to poor drug solubility and bioavailability. Recently, his work has expanded to exploring nasal-to-brain delivery routes, aiming to improve treatments for central nervous system disorders by bypassing the blood-brain barrier. He also investigates transdermal drug delivery systems, contributing to safer and more effective patient-centric therapeutic options.

Experience

Dr. Tekade has held academic positions ranging from lecturer to professor and head of department, spanning nearly three decades. He has taught undergraduate, postgraduate, and doctoral students, fostering the next generation of pharmaceutical scientists. He has supervised over 85 M.Pharm theses and 7 Ph.D. candidates, many of whom have gone on to contribute to academia and industry. Beyond teaching, he has managed multiple funded research projects from national agencies like the Department of Science & Technology (DST) and the Rajiv Gandhi Science & Technology Commission (RGSTC), cumulatively worth over Rs. 90 lakhs.

Research Timeline & Activities

Dr. Tekade began publishing research articles in 2005 and has since authored more than 60 peer-reviewed journal papers, book chapters, and conference proceedings. His pioneering studies on nanoparticulate drug delivery, dry powder inhalations, and solid dispersions have been well recognized in the scientific community. He has filed multiple patents related to pharmaceutical formulations and delivery technologies. Active participation in international conferences and workshops reflects his commitment to continuous learning and sharing knowledge globally.

Awards & Honors

Dr. Tekade’s contributions have been acknowledged through several prestigious awards. Among them, the Prof. Man Mohan Sharma Science & Technology Award presented by the Marathi Vidnyan Parishad, Mumbai, in 2019 stands out for recognizing his innovative work in pharmaceutical sciences. He has received grants and fellowships from leading science bodies and has been invited as a keynote speaker at various international symposia, showcasing his role as a thought leader in drug delivery research.

Top Noted Publication

One of Dr. Tekade’s most influential works is his chapter titled “Nanoparticles for direct nose-to-brain drug delivery: Implications of targeting approaches,” published in the book Direct Nose-to-Brain Drug Delivery by Academic Press in 2021. This publication is highly cited for advancing the understanding of how nanoparticulate carriers can bypass the blood-brain barrier to deliver drugs effectively for neurological conditions, thus opening new avenues in CNS therapeutics and nanomedicine.

  • Design and assessment of in-situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia
    Journal of Research in Pharmacy, 2025 (Open Access)
    This innovative study explores the development of a nasal gel formulation using nanostructured cubosomes aimed at enhancing targeted drug delivery for schizophrenia, highlighting novel approaches in neurotherapeutics.

  • RP-HPLC Method Development and Validation for the Determination of Remdesivir in IV Formulation
    Indian Drugs, 2025
    This article presents a validated reverse-phase high-performance liquid chromatography (RP-HPLC) method for accurately quantifying remdesivir in intravenous formulations, contributing essential analytical tools for pharmaceutical quality control.

  • Development and Evaluation of Remdesivir Dry Powder Inhalation Formulation by Spray Drying Technique
    Journal of Applied Pharmaceutical Science, 2025 (Open Access)
    This research focuses on the formulation of remdesivir as a dry powder for inhalation via spray drying, offering promising alternatives for pulmonary delivery of antiviral drugs.

  • Core-Shell Nanoparticles for Pulmonary Drug Delivery
    A comprehensive review discussing the design, advantages, and therapeutic applications of core-shell nanoparticles, emphasizing their potential for targeted and controlled pulmonary drug delivery.

Strengths for Pharmaceutical Innovation Award

  1. Pioneering Research in Nanotechnology-Based Drug Delivery:
    Dr. Tekade has extensively contributed to the development of innovative drug delivery systems, including nanoparticles, nanostructured cubosomes, and dry powder inhalations. His work on nasal-to-brain delivery and pulmonary drug formulations represents a cutting-edge approach to overcoming conventional therapeutic limitations, such as poor bioavailability and blood-brain barrier penetration.

  2. Significant Academic and Research Leadership:
    With over 27 years of academic experience, Dr. Tekade has demonstrated strong leadership as Professor, Head of Pharmaceutics, and Dean of Research & Development. His role in mentoring over 85 M.Pharm and 7 Ph.D. candidates highlights his dedication to nurturing future innovators in pharmaceutical sciences.

  3. High Impact Research and Recognition:
    Boasting an h-index of 21 and more than 1,683 citations, Dr. Tekade’s publications are widely acknowledged and influential in the field. His chapter on nose-to-brain drug delivery is recognized as a seminal work, shaping current understanding and future research directions in CNS drug targeting.

  4. Successful Management of Funded Research Projects:
    Dr. Tekade has secured and managed multiple competitive research grants totaling over Rs. 90 lakhs from reputed agencies such as DST and RGSTC. These projects underscore his capability to translate innovative ideas into funded, impactful research initiatives.

  5. Award-Winning Contributions and Global Engagement:
    Recipient of the prestigious Prof. Man Mohan Sharma Science & Technology Award, Dr. Tekade is recognized for his innovation and scientific excellence. His active participation as a keynote speaker in international forums reflects his status as a global thought leader driving pharmaceutical innovation.

Dipty Singh, Public Health, Female Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Dipty Singh, Public Health, Female Researcher Award

Dr. Dipty Singh: Scientist E and Head Neuroendocrinology Department at ICMR-NIRRCH, India

Dr. Dipty Singh is a highly accomplished scientist and educator with expertise in neuroendocrinology, reproductive health, and epigenetics. Currently serving as Scientist ‘E’ at ICMR-NIRRCH, Mumbai, she is also an Associate Professor at AcSIR. With over 15 years of research experience, Dr. Singh’s work bridges molecular biology, toxicology, and clinical medicine. Her research explores the impact of paternal epigenetic modifications on pregnancy outcomes and the role of environmental toxins like endocrine disruptors in reproductive health. She is a leading figure in the study of male infertility and epigenetics, and her contributions have been published in some of the top-tier journals globally.

Online Profiles

Google Scholar Profile

  • Citations: Total number of times your work has been cited by others.

    • 1054 citations overall, with 771 occurring since 2020.

  • h-index: Measures both productivity and citation impact. You have an h-index of 18, meaning you have 18 papers with at least 18 citations each.

    • An h-index of 16 since 2020 suggests recent work is having significant impact.

  • i10-index: Number of publications with 10 or more citations.

    • 24 papers overall, 21 of which have gained at least 10 citations since 2020 — a strong indicator of recent influence.

Education

Dr. Singh’s educational background laid a solid foundation for her multidisciplinary research career. She completed her Ph.D. in Life Sciences from the University of Mumbai in 2010, focusing on cellular and molecular biology. Prior to that, she earned a Master’s degree in Biotechnology from the University of Allahabad (2004), where she developed a strong interest in reproductive biology and toxicology. Her undergraduate studies at Magadh University in Chemistry, Botany, and Zoology sparked her initial curiosity about biological sciences, ultimately leading her to pursue an academic and research career in the life sciences.

Research Focus

Dr. Singh’s research interests are centered on the molecular and epigenetic mechanisms underlying male infertility, recurrent pregnancy loss, and pregnancy-related disorders. A significant portion of her work focuses on how environmental chemicals—especially endocrine disruptors such as phthalates and VOCs—affect reproductive health. Her studies delve into the paternal side of reproductive health, examining how sperm DNA methylation and epigenetic modifications can influence pregnancy outcomes, even in the absence of clear genetic mutations. She has also worked extensively on understanding how maternal nutrition and environmental exposures during gestation affect offspring reproductive health.

Experience

Dr. Singh’s career trajectory is a testament to her expertise and dedication. She has held pivotal roles at ICMR-NIRRCH, beginning as a Research Associate in 2010, before rising through the ranks to her current position as Scientist ‘E’ and Associate Professor. In addition to her work at ICMR-NIRRCH, Dr. Singh has served as a visiting faculty member at multiple institutions, including the University of Mumbai and the Institute of Science, Mumbai. Her academic leadership extends to her role as the Head of the Department of Neuroendocrinology and as the In-Charge of the Transmission Electron Microscopy Department at ICMR-NIRRCH, where she oversees cutting-edge research and collaborations.

Research Timeline & Activities

Dr. Singh’s research timeline reflects her continuous commitment to addressing critical issues in reproductive health. She has led numerous projects, including studies on sperm DNA epimutations as biomarkers for recurrent pregnancy loss and exploring the therapeutic potential of compounds like EGCG in improving fertility outcomes. Her research spans both basic science and clinical applications, as she works on various animal models and human clinical samples. Dr. Singh’s ongoing projects involve examining the impact of environmental toxins on reproductive health, and she has been the principal investigator for multiple ICMR-funded projects focusing on male infertility and endocrine disruption. Her work is highly collaborative, often involving interdisciplinary teams from multiple research institutions.

Awards & Honors

Dr. Singh has received numerous prestigious awards and fellowships in recognition of her outstanding contributions to biomedical research. She was awarded the ICMR-International Fellowship for Young Biomedical Scientists (2018-2019), which allowed her to collaborate with the American Center for Reproductive Medicine at the Cleveland Clinic, Ohio. Other notable honors include the Vice Chancellor Scholarship from the University of Mumbai, the Amy Rustomjee International Scholarship, and the DBT-RAship Postdoctoral Fellowship. In addition, Dr. Singh’s mentorship has been lauded, with her Ph.D. students winning awards such as the Dr. (Mrs.) Mridula Kamboj Young Scientist Award (2025) and the Dr. Shantarao Best Ph.D. Paper Award (2023).

Top Noted Publication

One of Dr. Singh’s most notable publications is the paper titled “Whole Genome Bisulfite Sequencing of Sperm Reveals Differentially Methylated Regions in Male Partners of Idiopathic Recurrent Pregnancy Loss Cases,” published in Fertility and Sterility in 2023. This study, with an impact factor of 7.49, provided significant insights into the epigenetic factors affecting male fertility, specifically focusing on sperm DNA methylation and its role in recurrent pregnancy loss. This work is part of a broader effort by Dr. Singh to bridge gaps between epigenetic research and clinical applications, making her a leading expert in the field of reproductive epigenetics. In total, she has authored over 40 publications in high-impact journals, establishing her as a key figure in the scientific community’s understanding of reproductive health and epigenetics.

  • Durairajanayagam D, Singh D, Agarwal A, Henkel R
    Causes and consequences of sperm mitochondrial dysfunction
    Andrologia 53(1), e13666, 2021
    Citations: 156

  • Thakur M, Gupta H, Singh D, Mohanty IR, Maheswari U, Vanage G, …
    Histopathological and ultrastructural effects of nanoparticles on rat testis following 90 days (chronic study) of repeated oral administration
    Journal of Nanobiotechnology 12(1), 42, 2014
    Citations: 144

  • Singh D, Fulekar MH
    Benzene bioremediation using cow dung microflora in two-phase partitioning bioreactor
    Journal of Hazardous Materials 175(1–3), 336–343, 2010
    Citations: 87

  • Kumar A, Banerjee A, Singh D, Thakur G, Kasarpalkar N, Gavali S, …
    Estradiol: A steroid with multiple facets
    Hormone and Metabolic Research 50(5), 359–374, 2018
    Citations: 75

  • Surve MV, Bhutda S, Datey A, Anil A, Rawat S, Pushpakaran A, Singh D, …
    Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking
    PLoS Pathogens 14(7), e1007168, 2018
    Citations: 56

Strength for the Female Researcher Award

1. Breaking Barriers in Reproductive Epigenetics

Highlight Dr. Singh’s pioneering work on paternal epigenetic modifications and their impact on pregnancy outcomes, a field long underexplored — especially by women scientists. This theme would celebrate her contribution to redefining male infertility research.

2. From Bench to Bedside: Translating Molecular Science into Clinical Impact

Focus on how her basic research (e.g., sperm DNA methylation, endocrine disruptors) is driving real-world clinical insights into recurrent pregnancy loss and infertility, especially in Indian populations.

3. Leadership in Science: From Researcher to Department Head

Celebrate her rise from a research associate to Scientist E and Head of Neuroendocrinology at ICMR-NIRRCH — reflecting resilience, leadership, and her mentorship to the next generation of researchers, particularly women.

4. Championing Women in STEM Through Research, Mentorship, and Education

Dr. Singh’s journey as a woman leading cutting-edge labs, mentoring award-winning PhD students, and shaping national research programs illustrates empowerment and dedication to uplifting women in science.

5. Environmental Justice Through Reproductive Health Research

This theme would emphasize her research on how environmental exposures (e.g., phthalates, VOCs) disproportionately affect reproductive health, connecting public health, environmental safety, and gender equity in research.